- Home
- Publications
- Publication Search
- Publication Details
Title
Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-19
DOI
10.3389/fimmu.2021.614255
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-17A and TNF Modulate Normal Human Spinal Entheseal Bone and Soft Tissue Mesenchymal Stem Cell Osteogenesis, Adipogenesis, and Stromal Function
- (2021) Tobias Russell et al. Cells
- Interleukin‐23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy
- (2020) Charlie Bridgewood et al. IMMUNOLOGICAL REVIEWS
- The psychological impact of quarantine and how to reduce it: rapid review of the evidence
- (2020) Samantha K Brooks et al. LANCET
- TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis
- (2020) Eric Gracey et al. JOURNAL OF CLINICAL INVESTIGATION
- Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
- (2020) Atul Deodhar et al. LANCET
- Response to: ‘Correspondence to ‘Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression’’ by Wang and Ma
- (2020) Abdulla Watad et al. ANNALS OF THE RHEUMATIC DISEASES
- Intestinal and enthesis innate immunity in early axial spondyloarthropathy
- (2020) Kassem Sharif et al. RHEUMATOLOGY
- Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results
- (2019) Philip Mease Arthritis & Rheumatology
- Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders
- (2019) Simone Garcovich et al. Frontiers in Pharmacology
- Mutual interplay between IL-17–producing γδT cells and microbiota orchestrates oral mucosal homeostasis
- (2019) Anneke Wilharm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Revisiting the combinatorial potential of cytokine subunits in the IL-12 family
- (2019) Sammy Detry et al. BIOCHEMICAL PHARMACOLOGY
- Identification of myeloid cells in the human enthesis as the main source of local IL-23 production
- (2019) Charlie Bridgewood et al. ANNALS OF THE RHEUMATIC DISEASES
- The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man
- (2019) Charlie Bridgewood et al. INFLAMMATION RESEARCH
- Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression
- (2019) Richard James Cuthbert et al. ANNALS OF THE RHEUMATIC DISEASES
- Is undifferentiated spondyloarthritis a discrete entity? A debate
- (2018) Atul Deodhar et al. AUTOIMMUNITY REVIEWS
- Nature versus nurture in the spectrum of rheumatic diseases: Classification of spondyloarthritis as autoimmune or autoinflammatory
- (2018) Elena Generali et al. AUTOIMMUNITY REVIEWS
- Spondyloarthritis
- (2018) Charlie Bridgewood et al. CURRENT OPINION IN RHEUMATOLOGY
- Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
- (2018) Mark Fleisher et al. DIGESTIVE DISEASES AND SCIENCES
- Diet Modifies Colonic Microbiota and CD4 + T Cell Repertoire to Induce Flares of Colitis in Mice With Myeloid-cell Expression of Interleukin 23
- (2018) Lili Chen et al. GASTROENTEROLOGY
- The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates
- (2018) Farhad Babaie et al. IMMUNOLOGY LETTERS
- Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
- (2018) Marie-Astrid Boutet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
- (2018) Douglas J Veale et al. RHEUMATOLOGY
- Enthesitis: Much More Than Focal Insertion Point Inflammation
- (2018) Abdulla Watad et al. Current Rheumatology Reports
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
- (2018) Dominique Baeten et al. ANNALS OF THE RHEUMATIC DISEASES
- The SKG model of spondyloarthritis
- (2018) M. Arifur Rahman et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease
- (2018) Sayam Dubash et al. RHEUMATOLOGY
- Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
- (2018) Atul Deodhar et al. Arthritis & Rheumatology
- Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?
- (2018) Stefan Siebert et al. ANNALS OF THE RHEUMATIC DISEASES
- The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond
- (2018) Sayam Dubash et al. Expert Review of Clinical Immunology
- Regression of peripheral subclinical enthesopathy in therapy-naïve patients treated with Ustekinumab for moderate-to-severe chronic plaque psoriasis
- (2018) Laura Savage et al. Arthritis & Rheumatology
- The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science
- (2018) Abdulla Watad et al. Frontiers in Immunology
- Genetics and Functional Genomics of Spondyloarthritis
- (2018) Félicie Costantino et al. Frontiers in Immunology
- Ustekinumab for Crohn’s Disease
- (2017) Reena Khanna et al. GASTROENTEROLOGY
- Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease
- (2017) Megan Hohenberger et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Enthesitis: from pathophysiology to treatment
- (2017) Georg Schett et al. Nature Reviews Rheumatology
- Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis
- (2017) Richard J. Cuthbert et al. Arthritis & Rheumatology
- Innate Immune Activation Can Trigger Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats
- (2017) Melissa N. van Tok et al. Frontiers in Immunology
- Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications
- (2017) Myriam Lawand et al. Frontiers in Immunology
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
- (2016) Stephan R Targan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)
- (2016) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis
- (2016) Katelijne De Wilde et al. ANNALS OF THE RHEUMATIC DISEASES
- An update on biomarkers in axial spondyloarthritis
- (2016) Klára Prajzlerová et al. AUTOIMMUNITY REVIEWS
- Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA
- (2016) Aoibhlinn O’Toole et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study
- (2016) A. Kavanaugh et al. JOURNAL OF RHEUMATOLOGY
- IL-12 protects from psoriasiform skin inflammation
- (2016) Paulina Kulig et al. Nature Communications
- Interleukin-23-Dependent γ/δ T Cells Produce Interleukin-17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice
- (2016) Annika Reinhardt et al. Arthritis & Rheumatology
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- The immunogenetics of Behçet's disease: A comprehensive review
- (2015) Masaki Takeuchi et al. JOURNAL OF AUTOIMMUNITY
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- Genetics of ankylosing spondylitis—insights into pathogenesis
- (2015) Matthew A. Brown et al. Nature Reviews Rheumatology
- 'MHC-I-opathy'—unified concept for spondyloarthritis and Behçet disease
- (2015) Dennis McGonagle et al. Nature Reviews Rheumatology
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- γδT Cells: First Line of Defense and Beyond
- (2014) Yueh-hsiu Chien et al. Annual Review of Immunology
- Interleukin-23 Mediates the Intestinal Response to Microbial β-1,3-Glucan and the Development of Spondyloarthritis Pathology in SKG Mice
- (2014) Helen Benham et al. Arthritis & Rheumatology
- Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
- (2013) Iain B McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells
- (2013) Peggy Jacques et al. ANNALS OF THE RHEUMATIC DISEASES
- Brief Report: Magnetic Resonance Imaging Assessment of Axial Psoriatic Arthritis: Extent of Disease Relates to HLA-B27
- (2013) Concepción Castillo-Gallego et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential
- (2013) Alice Gottlieb et al. Therapeutic Advances in Musculoskeletal Disease
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease
- (2011) S. W. Kim et al. GUT
- IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass
- (2011) I. E. Adamopoulos et al. JOURNAL OF IMMUNOLOGY
- The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
- (2011) Paola Di Meglio et al. PLoS One
- Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses
- (2011) R. Sarin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Low-strength T-cell activation promotes Th17 responses
- (2010) H. A. Purvis et al. BLOOD
- Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial
- (2010) Arthur Kavanaugh et al. CURRENT MEDICAL RESEARCH AND OPINION
- IL-23/IL-17 axis in IBD
- (2010) Massimiliano Sarra et al. INFLAMMATORY BOWEL DISEASES
- Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease
- (2009) Kai Wang et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Spondylarthritis in HLA-B27/human β2-microglobulin-transgenic rats is not prevented by lack of CD8
- (2009) Joel D. Taurog et al. ARTHRITIS AND RHEUMATISM
- Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine
- (2008) Ivaylo I. Ivanov et al. Cell Host & Microbe
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search